Mereo BioPharma Group plc (MAH0) — Financial Flexibility Index
Mereo BioPharma Group plc (MAH0) has a Financial Flexibility Index of -1.54x as of December 2025. Free cash flow of €-7.68 Million (operating CF €-7.68 Million minus capex €0.00) represents -2% of total liabilities (€5.00 Million). Also explore Mereo BioPharma Group plc annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Mereo BioPharma Group plc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Mereo BioPharma Group plc across 10 annual periods. Check MAH0 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Mereo BioPharma Group plc (2016–2025)
Year-by-year free cash flow to debt coverage for Mereo BioPharma Group plc. For the full company profile including market capitalisation, see MAH0 company net worth.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -6.13x | €-30.65 Million | €-30.97 Million | €5.00 Million | ▼ -194.1% |
| 2024 | -2.08x | €-32.13 Million | €-32.83 Million | €15.42 Million | ▼ -60.6% |
| 2023 | -1.30x | €-20.71 Million | €-21.13 Million | €15.96 Million | ▲ +12.4% |
| 2022 | -1.48x | €-38.81 Million | €-38.82 Million | €26.21 Million | ▼ -1109.2% |
| 2021 | -0.12x | €-4.70 Million | €-5.24 Million | €38.41 Million | ▲ +66.3% |
| 2020 | -0.36x | €-28.32 Million | €-28.34 Million | €77.92 Million | ▲ +63.4% |
| 2019 | -0.99x | €-45.91 Million | €-45.93 Million | €46.19 Million | ▼ -48.4% |
| 2018 | -0.67x | €-23.11 Million | €-23.14 Million | €34.51 Million | ▲ +29.5% |
| 2017 | -0.95x | €-32.13 Million | €-32.15 Million | €33.85 Million | ▲ +76.0% |
| 2016 | -3.95x | €-29.66 Million | €-29.66 Million | €7.51 Million | — |